Julian Symons
Executive Vice President, Chief Scientific Officer at Aligos Therapeutics
South San Francisco, California, United States
Find your path to Julian
213 people in our graph share verified history with Julian — schools, employers, funds. One of them is your warm intro.
Mike FitzgeraldunlockedJulian: together at F. Hoffmann-La Roche (2001)
×6Julian: together at F. Hoffmann-La Roche
×3Julian: together at University of York
Julian: together at Aligos Therapeutics
Executive Vice President, Chief Scientific Officer at Aligos Therapeutics
Intro paths
→
In turn, Julian can intro founders to Aligos Therapeutics's investors below.
Aligos Therapeutics's investors · 3
Co-founders at Aligos Therapeutics
LB
Leonid BeigelmanPresident
LM
Lawrence M. BlattChairman, President & CEO (Co-founder)
Experience
- Aligos TherapeuticsCSOcurrent2018 — presentSouth San Francisco
- Aligos TherapeuticsChief Scientific Officercurrent2018 — presentSouth San Francisco
- Alios BioPharma, Inc., a Janssen Pharmaceutical Company of Johnson and JohnsonVice President, Disease Area Research & Development Leader, Respiratory Infections2015 — 2018South San Francisco
- Alios BioPharmaSenior Director, Product Development2013 — 2015
- Alios BioPharmaDirector of Product Development2010 — 2013
- Roche Palo AltoAssociate Director2001 — 2010
- F. Hoffmann-La RocheResearch Scientist1999 — 2001Roche Discovery Welwyn
Skills & more
VirologyImmunology
From Julian's professional profile.
Frequently asked questions
- Who is Julian Symons?
- Executive Vice President, Chief Scientific Officer at Aligos Therapeutics
- Where does Julian Symons work?
- Julian Symons is Executive Vice President, Chief Scientific Officer at Aligos Therapeutics.
- Where did Julian Symons go to school?
- Julian Symons studied at University of York (D.Phil., Immunology, Autoimmunity); University of Lancashire (B.Sc. (Hons), Biochemistry, Physiology).
Same school
Also attended University of York102
Bob ThomasPartner at OxxNicole QuinnCo-Founder and Managing Partner at Connect VenturesPhil VenablesVenture Partner at Ballistic VenturesAnthony AvedissianPartner at Canonical CryptoConor ScanlanAssociate Partner at Nauta CapitalChris McCourtInvestment Director at Mercia Ventures
+ 96 more
Also attended University of Lancashire22
Ashley MarshallDirector of PR and Marketing at QED InvestorsBrian CummingsInvestment Director at Clarendon Fund Managers Ltd.Jörg RiekerFounding Partner at MaximonKunal DaveySenior Vice President at Anicut CapitalJainish RathodInvestment, AEC & Built World at SevenTrainVenturesMichelle KirkwoodSenior Director, HR Business Partner at Toronto Innovation Acceleration Partners
+ 16 more
Shared employers
Also worked at Aligos Therapeutics9
Bridget Martell MA, MDSenior Biopharmaceutical Advisor at Two Bear CapitalJack NielsenManaging Partner at Vivo CapitalPierre RaboissonChief Executive Officer Chief Scientific Officer Co-founder at CoultreonFrançois GonzalvezCo-founder at CoultreonSandrine VendevilleCo-founder at CoultreonHardean AchneckExecutive Officer at Aligos Therapeutics
+ 3 more
Also worked at Alios BioPharma, Inc., a Janssen Pharmaceutical Company of Johnson and Johnson94
Patrick LoerchBio Advisor at Amplify PartnersUmut EserVenture Partner at Magnetic VenturesLance BermanVenture Partner at Ysios CapitalJuan CuevaDirector, Early Innovation Partnering at Johnson & Johnson at Joyance PartnersPatrick ForsterInvestment Analyst at The Spartan GroupMichael KalosInvestor at 82VS
)
+ 88 more
Also worked at Alios BioPharma3
Also worked at Roche Palo Alto228
Joe HorsmanInvestor at Madrona Venture GroupMarco PrunottoInvestor at MedicxiMike FitzgeraldInvestor at High AlphaUri LopatinInvestor at Khosla VenturesJan-Olivier FillolsSenior Managing Director at Marlin Equity PartnersCyndi ReseburgInvestor at Initialized Capital
+ 222 more